We then studied the therapeutic effectiveness of ASP in an adenine-induced rat model of CKD that developed renal damage, anemia, inflammation, impaired EPO production, inactivation of EPO receptor signaling and disordered iron metabolism. Here, EPO is linked to anemia (phenotype).